You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
McKinsey
Dow
AstraZeneca
Express Scripts

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

BECONASE Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Which patents cover Beconase, and when can generic versions of Beconase launch?

Beconase is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in BECONASE is beclomethasone dipropionate monohydrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.

Drug patent expirations by year for BECONASE
Drug Prices for BECONASE

See drug prices for BECONASE

Recent Clinical Trials for BECONASE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West Penn Allegheny Health SystemPhase 4
Glaucoma Research Society of CanadaN/A
University Health Network, TorontoN/A

See all BECONASE clinical trials

Recent Litigation for BECONASE

Identify potential future generic entrants

District Court Litigation
Case NameDate
MERCK SHARP & DOHME CORP. v. APOTEX INC.2009-12-18

See all BECONASE litigation

Synonyms for BECONASE
(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione
(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2-[(1R,2S,10S,11S,13S,14R,15S,17S)-1-chloro-17-hydroxy-2,13,15-trimethyl-5-oxo-14-(propanoyloxy)tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-14-yl]-2-oxoethyl propanoate
32278-EP2281815A1
32278-EP2295408A1
32278-EP2301933A1
32278-EP2305640A2
32278-EP2311827A1
34135-07-4
534B098
5534-09-8
5B307S63B2
9-AE-11|A,17,21-EyoC>>u-16|A-(1/4)x>>uOEthcThorn-1,4- paragraph signthornI(c)-3,20- paragraph signthornI feminine-17,21- paragraph signthorn+/-uEao yen
9-Chloro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11|A,17,21-trihydroxy-16|A-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11beta, 17,21-trihydroxy-16 beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-chloro-16beta-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate
AB1009261
AC-2159
AC1L2IWA
AC1Q62MZ
Aerobec
AKOS015951275
Alanase
Aldecin
Aldecina
Aldecine
AN-14214
API0001601
Atomase
B4464
Beclacin
Beclate
Beclazone
Beclazone 250
Beclocort Nasel
Becloforte
Beclomet
Beclomet Nasal
Beclometasone (beclomethasone) dipropionate, British Pharmacopoeia (BP) Assay Standard
Beclometasone 17,21-dipropionate
Beclometasone dipropionate
Beclometasone dipropionate (JP17)
Beclometasone dipropionate for peak identification, European Pharmacopoeia (EP) Reference Standard
Beclometasone dipropionate for system suitability, European Pharmacopoeia (EP) Reference Standard
Beclometasone dipropionato
BECLOMETHASONE DIPROPIONATE
Beclomethasone dipropionate (USP)
Beclomethasone dipropionate [USAN:USP]
Beclomethasone dipropionate [USAN]
Beclomethasone dipropionate, analytical standard, for drug analysis
Beclomethasone dipropionate, anhydrous, European Pharmacopoeia (EP) Reference Standard
Beclomethasone Dipropionate, Pharmaceutical Secondary Standard; Certified Reference Material
Beclomethasone dipropionate, United States Pharmacopeia (USP) Reference Standard
Beclorhinol
Becloturmant
Beclovent
Beclovent (TN)
Beconase AQ
Benconase
BPBio1_000957
BRD-K97810537-001-03-7
BRD-K97810537-001-13-6
BSPBio_000869
C07813
C28H37ClO7
CAS-5534-09-8
CCG-220855
CHEBI:3002
CHEMBL1200500
Clenil
Clenil-A
CPD001233361
CS-1503
CTK8F7938
D00689
DB00394
DSSTox_CID_28656
DSSTox_GSID_48730
DSSTox_RID_82926
DTXSID3048730
EINECS 226-886-0
Entyderma
GTPL5894
HMS1570L11
HMS2097L11
HMS2235O23
HMS3259H03
HMS3714L11
HY-13571A
Inalone O
Inalone R
Korbutone
KUVIULQEHSCUHY-XYWKZLDCSA-N
KW-053
LS-118439
Menaderm
MFCD00135613
MLS002154034
MolPort-003-983-412
NC00610
NCGC00094596-03
NCGC00179392-01
Pregna-1-4-diene-3,20-dione, 9-chloro-16-beta-methyl-11-beta,17,21-trihydroxy-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-chloro-16-beta-methyl-11-beta,17,21-trihydroxy-, 17,21-dipropionate
Prestwick_990
Prestwick0_000855
Prestwick1_000855
Prestwick2_000855
Prestwick3_000855
Propaderm
Propaderm Forte
Propionic acid beclomethasone
QNASL
Qnasl (TN)
Qvar
QVAR 40
Qvar 80
Respocort
Rhino Clenil
Rhinosol
Rino-clenil
s3078
Sanasthmax
Sanasthmyl
SCH 18020W
SCHEMBL6890
SMR001233361
SPBio_002790
Spir
ST24046007
Tox21_113168
Turbinal
UNII-5B307S63B2
Vancenase
Vanceril
Vanceril (TN)
Vanceril Double Strength
Ventolair
Viarox
W-5080
ZINC3938744

US Patents and Regulatory Information for BECONASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline BECONASE beclomethasone dipropionate AEROSOL, METERED;NASAL 018584-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline BECONASE AQ beclomethasone dipropionate monohydrate SPRAY, METERED;NASAL 019389-001 Jul 27, 1987 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for BECONASE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline BECONASE beclomethasone dipropionate AEROSOL, METERED;NASAL 018584-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Glaxosmithkline BECONASE beclomethasone dipropionate AEROSOL, METERED;NASAL 018584-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Mallinckrodt
Merck
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.